Gemcitabine (1000 mg)

admin — Wed, 18 Feb 2026 10:55:09 +0000

Overview: Pazopanib 200 mg Tablets contain Pazopanib (200 mg) and are prescribed as an oral targeted anticancer medicine used in the treatment of advanced renal cell carcinoma (kidney cancer) and certain soft tissue sarcomas by inhibiting tyrosine kinases associated with tumor growth and blood vessel formation. Key Benefits: – Inhibits tumor angiogenesis and growth – Oral dosing for convenient outpatient therapy – Used in advanced renal cell carcinoma and select sarcoma protocols Composition: Pazopanib (200 mg) How It Works: Pazopanib is a multi-targeted tyrosine kinase inhibitor that blocks vascular endothelial growth factor receptors (VEGFR), platelet-derived growth factor receptors (PDGFR), and other kinases, reducing tumor blood supply and growth. Usage Instructions: – Take exactly as directed by your oncologist – Swallow the tablet with water, usually once daily – Do not crush or chew the tablet Side Effects: – Diarrhea, nausea, vomiting – Hypertension, fatigue – Liver enzyme elevations, hair color changes Precautions: – Monitor liver function and blood pressure regularly during treatment – Not recommended during pregnancy or breastfeeding unless advised by a physician – Inform your doctor of all current medications Storage Instructions: – Store below 30°C in a cool, dry place away from moisture and light Manufacturer: Generic Pharmaceuticals Disclaimer: To be sold by retail on the prescription of a registered medical practitioner only.

soft tissue sarcoma medicine – Globalstar International

Gemcitabine (1000 mg)